IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

We compared hematologic and clinical effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) after treatment with high-dose cyclophosphamide (HD-CTX, 7 g/m2), given as the first phase of a high-dose sequential chemotherapy program that includes a myeloablative therapy with mobilized progenitor cell autografting.

Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy / M. Bregni, S. Siena, M. Di Nicola, A. Dodero, F. Peccatori, F. Ravagnani, G. Danesini, A. Laffranchi, G. Bonadonna, A. M. Gianni. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 14:2(1996 Feb), pp. 628-35-635.

Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy

S. Siena;A. M. Gianni
1996

Abstract

We compared hematologic and clinical effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) after treatment with high-dose cyclophosphamide (HD-CTX, 7 g/m2), given as the first phase of a high-dose sequential chemotherapy program that includes a myeloablative therapy with mobilized progenitor cell autografting.
English
Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Adult; Breast Neoplasms; Middle Aged; Cyclophosphamide; Antineoplastic Agents, Alkylating; Lymphoma, Non-Hodgkin; Hodgkin Disease; Male; Female
Settore MED/06 - Oncologia Medica
Articolo
Esperti anonimi
feb-1996
14
2
628-35
635
Pubblicato
Periodico con rilevanza internazionale
Pubmed
WOS:A1996TU99800043
2-s2.0-9044236165
W2222012486
8636780
info:eu-repo/semantics/article
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy / M. Bregni, S. Siena, M. Di Nicola, A. Dodero, F. Peccatori, F. Ravagnani, G. Danesini, A. Laffranchi, G. Bonadonna, A. M. Gianni. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 14:2(1996 Feb), pp. 628-35-635.
none
Prodotti della ricerca::01 - Articolo su periodico
10
262
Article (author)
no
M. Bregni, S. Siena, M. Di Nicola, A. Dodero, F. Peccatori, F. Ravagnani, G. Danesini, A. Laffranchi, G. Bonadonna, A. M. Gianni
01 - Articolo su periodico
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/184563
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 35
  • OpenAlex 32
social impact